Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

endTB (Expand New Drugs for TB) Observational Study: Treatment of MDR-TB With Regimens Containing Bedaquiline or Delamanid

NCT03259269 is registered in ClinicalTrials.gov with Partners in Health as lead sponsor.

NCT NCT03259269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03259269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
endTB (Expand New Drugs for TB) Observational Study: Treatment of MDR-TB With Regimens Containing Bedaquiline or Delamanid
Lead sponsor
Partners in Health
Phase
Observational
Overall status
Completed
Start date
April 1, 2015
Completion date
December 30, 2019
Enrollment
2,804 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, multidrug-resistant